HeraMED Limited (ASX:HMD)
0.0420
0.00 (0.00%)
Mar 18, 2026, 3:37 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 46.88 million as of March 18, 2026. Its market cap has increased by 214.97% in one year.
Market Cap
46.88M
Enterprise Value
45.51M
Revenue
431.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 46.88M, an increase of 197.58%. That is a compound annual growth rate of 16.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 46.88M | 21.69% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 144.17M |
| Cleo Diagnostics | 68.43M |
| Compumedics | 60.93M |
| Micro-X | 47.20M |
| Nova Eye Medical | 42.73M |
| CleanSpace Holdings | 37.48M |
| ImpediMed | 32.62M |
| Atomo Diagnostics | 29.17M |